G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/14/2002	WO2002089837A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089744A2 Combined treatments and methods of treatment of mycoplasma and mycoplasma-like organism infections
11/14/2002	WO2002089737A2 Separation of platelets from whole blood for use as a healant
11/14/2002	WO2002089736A2 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
11/14/2002	WO2002089733A2 Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
11/14/2002	WO2002089731A2 Agents for treatment of hcv and methods of use
11/14/2002	WO2002089657A2 Diagnostic markers of acute coronary syndromes and methods of use thereof
11/14/2002	WO2002089656A2 Diagnosis of acute myocardial infarction
11/14/2002	WO2002089567A2 Sca2 knockout animal and methods of use
11/14/2002	WO2002089566A1 Interstitial prostatism model animal
11/14/2002	WO2002079393A9 Dynamic action reference tools
11/14/2002	WO2002077259A3 Biochips including ion transport detecting structures and methods of use
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002072126A3 Invention relating to hcv diseases
11/14/2002	WO2002070679A3 Peptide fragments, derived from human telomerase reverse transcriptase
11/14/2002	WO2002067764A3 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/14/2002	WO2002066028A3 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/14/2002	WO2002055026A3 Perfluoro sulfonyl halides and related species as polymer support modifiers
11/14/2002	WO2002053713A3 Cloning of a human sulfotransferase
11/14/2002	WO2002052260A3 Biosensor and method of producing the same
11/14/2002	WO2002050533B1 Method and apparatus for measuring fibre properties
11/14/2002	WO2002049634A3 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
11/14/2002	WO2002042773A3 An extended tethering approach for rapid identification of ligands
11/14/2002	WO2002032944A3 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2002025282A3 Method for adhesion of polymers to metal-coated substrates
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	WO2002006825A3 Biochemical markers of the human endometrium
11/14/2002	WO2001098785B1 Rapid flow-based immunoassay microchip
11/14/2002	WO2001073446A8 Alpha 7 nicotinic receptor screening assays
11/14/2002	WO2001062984A3 Detection of human papilloma viruses
11/14/2002	WO2001048244A3 Detection of single nucleotide polymorphisms
11/14/2002	WO2001036659A3 Selectable cell surface marker genes
11/14/2002	WO2001035106A3 Methods for identifying and using amyloid-inhibitory compounds
11/14/2002	WO2001033228A3 Cancer diagnosis employing cell-sorting and gene-profiles
11/14/2002	WO2001011358A3 Use of colored metal binding proteins
11/14/2002	WO2001007030A3 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs
11/14/2002	US20020169567 Method and apparatus for identifying unknown compounds in complex chemical mixtures using mass spectrometry and mass differential analysis
11/14/2002	US20020169562 Defining biological states and related genes, proteins and patterns
11/14/2002	US20020169561 Modular computational models for predicting the pharmaceutical properties of chemical compunds
11/14/2002	US20020169560 Analysis mechanism for genetic data
11/14/2002	US20020169557 Estimation of toxic substance release
11/14/2002	US20020169393 Method and apparatus for obtaining blood for diagnostic tests
11/14/2002	US20020169391 Devices, methods and systems for collecting material from a breast duct
11/14/2002	US20020169370 Viscosity measuring apparatus and method of use
11/14/2002	US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169293 Microsphere for use in tools in the detection of preferential receptors and drug screening
11/14/2002	US20020169292 Human glycoprotein hormone for use in the prevention and treatment of metabolic and sexual disorders
11/14/2002	US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169278 Polypeptides for diagnosis of myocardial infarction, intracerebral hemorrhage, or congestive heart failure
11/14/2002	US20020169230 Comprises ethylene-vinyl acetate-carbon monoxide copolymer compatabilized with 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one; for preparing plastics
11/14/2002	US20020169151 Administering to a mammal,in the absence of estrogen or an agonist, an amount of progesterone or an agonist effective to decrease vascular smooth muscle cell proliferation in the mammal
11/14/2002	US20020169143 Methods and products related to low molecular weight heparin
11/14/2002	US20020169137 Preventing or inhibiting pathological beta-amyloid plaque formation in conditions such as Alzheimer's disease
11/14/2002	US20020169118 TNF receptors, TNF binding proteins and DNAs coding for them
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169115 Method of predicting resistance to hepatitis C infection
11/14/2002	US20020169112 Antibiotics combined with antioxidants to reduce oxidative stresses; improves host cell resistance to oxidative stress while reducing mycoplasma infection levels; methods of HIV therapy
11/14/2002	US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002	US20020168784 Agglutination assays
11/14/2002	US20020168783 Reagents and methods useful for detecting diseases of the prostate
11/14/2002	US20020168782 Apparatus for use inthe detection of allergen preferential immunoglobulin in sample
11/14/2002	US20020168781 Kit for use in the detection of pregnancy
11/14/2002	US20020168779 Apparatus for use in the generation and storage of libraries of human cells
11/14/2002	US20020168776 Detecting preferential particle in sample; obtain sample, incubate in matrix, illuminate surface, recover light from surface, determine concentration of particle in sample
11/14/2002	US20020168775 Determination of corticosteroids in human plasma using micromass LC/MS/MS/
11/14/2002	US20020168774 Method for the analysis of the metal chelates of amino acids especially for use in the European Union
11/14/2002	US20020168772 Method of detecting poisoning of a MOS gas sensor
11/14/2002	US20020168757 Test device and method of making same
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168753 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168748 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168725 Protein for use in the diagnosis, treatment and prevention of nervous system disorders
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168722 Adjusted fibrinogen for use in the treatment blood clotting disorders
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168702 Isolating cells expressing secreted proteins
11/14/2002	US20020168700 Measuring Factor VIIa activity in sample; obtain sample, incubate with buffer and substrate, measure amount of catalyzed substrate, catalyzed substrate indicates factor VIIA activity
11/14/2002	US20020168699 Detecting preferential drug in sample; obtain antigens, immobilize to solid support, incubate with sample and colorigenic substrate, detect signal
11/14/2002	US20020168698 Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker
11/14/2002	US20020168697 Antimicrobial methods and materials
11/14/2002	US20020168696 Annexin proteins and autoantibodies as serum markers for cancer
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168692 Biosensor detector array
11/14/2002	US20020168691 Methods and kits useful for the simplification of complex peptide mixtures
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168688 High throughput screening assay systems in microscale fluidic devices
11/14/2002	US20020168687 Inhibition of tau-tau-association

1 ... 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 ... 3937